Biotechnology Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD 2024 International Conference – Athira Pharma (NASDAQ:ATHA) Read more
Biotechnology Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates – Athira Pharma (NASDAQ:ATHA) Read more
Biotechnology Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS) – Athira Pharma (NASDAQ:ATHA) Read more
